Filed with the SEC on · Summarized by InvestorsBot
Michael E. Prevoznik, Quest Diagnostics’ SVP and General Counsel, sold 16,010 shares at $242.88 each for approximately $3.89 million, leaving him with 44,224 shares. He also sold 6,237 shares at $243.63 each for about $1.52 million and 430 shares at $244.51 each for about $105,000; he owned 37,987 and 37,557 shares, respectively, after those sales.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeQuest Diagnostics raises 2026 revenue and EPS guidance after strong third quarter
8-K · October 22, 2026
Quest Diagnostics Reports Unauthorized Access to Quanum LSM System
8-K · October 22, 2026
Quest Diagnostics Executive Catherine Doherty to Retire in July 2027
8-K · October 6, 2026
Quest Diagnostics CEO Davis J. E. sells $2.4M in stock
Form 4 · Insider Trade · September 3, 2026
Quest Diagnostics Reports Q2 Growth and Raises 2026 Guidance
8-K · July 23, 2026
Quest Diagnostics ($DGX) filed a Form 8‑K on Mar 12, 2026 — Item 9.01 lists exhibits: Press release dated…
8-K · March 12, 2026